Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Non Operating Interest Expenses (2024 - 2026)

Updated

Adaptin Bio's Non Operating Interest Expenses came in at $4,696 for Q2 2026, up 141.7% from the prior quarter.

Analysis

Adaptin Bio (APTN) Non Operating Interest Expenses (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Adaptin Bio reported Non Operating Interest Expenses of $6,639, down 98.0% year-over-year; for FY2025, it was $72,659, down 78.7% from FY2024.

  • Going back by year, Non Operating Interest Expenses was $341,048 in FY2024.
  • The Q2 2026 figure represents the highest quarterly Non Operating Interest Expenses since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Adaptin Bio 56.76 Mn 54.75 Mn - 4,696.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,696.00
Mar 31, 2026 1,943.00
Mar 31, 2025 72,659.00
Dec 31, 2024 145,887.00
Sep 30, 2024 106,553.00
Jun 30, 2024 49,045.00
Mar 31, 2024 39,563.00
API Access

Adaptin Bio Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=APTN&period=max&api_key=YOUR_API_KEY